Molecular basis of β-thalassemia in Bahrain: An epicenter for a Middle East specific mutation

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 407-409

  Jassim, N ^a,b   Merghoub, T ^a   Pascaud, O ^a   Al Mukharraq, H ^b   Ducrocq, R ^a   Labie, D ^a   Elion, J ^a   Krishnamoorthy, R ^a   Arrayed, S A L ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b SALMANIYA MEDICAL COMPLEX   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

BAHRAIN; BETA THALASSEMIA; CONFERENCE PAPER; GENE FREQUENCY; GENE MUTATION; GLOBIN GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY;

EID: 0031873069     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10505.x     Document Type: Conference Paper

References (4)

1. NADKARNI, K. V. et al. 1991. Incidence of genetic disorders of hemoglobin in the hospital population of Bahrain. Bahrain Med. Bull. 13(1): 19-24.
2. MAGGIO, A. et al. 1993. Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean β-thalassemia mutations by covalent reverse dot-blot analysis: Application to prenatal diagnosis in Sicily. Blood 81: 239-242.
3. CAI, S. P. et al. 1994. Reverse dot blot probes for screening of β-thalassemia mutations in Asians and American blacks. Hum. Mutat. 3: 59-63.
4. GHANEM, N. et al. 1992. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum. Mutat. 1: 229-239.